Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital, Private Equity
Stage Focus
Seed, Early Stage, Series A, Series B, Growth
Geographical Focus
United Kingdom
Industries Focus
- Technology
- Healthcare
- Artificial Intelligence
- Robotics
- Climate Tech
- Industrial Tech
- Advanced Materials
- Photonics
Investment Size:
3,000,000 to 30,000,000 USD
Investor Details Founded: 2008
Par Equity is a prominent venture capital firm based in Edinburgh, Scotland, specializing in early-stage investments in innovative technology companies with high growth potential across the North of the United Kingdom. Founded in 2008, the firm has invested over £160 million across 77 companies, leveraging an additional £268 million from third-party investors. Their investment approach combines the professionalism and rigor of a venture capital manager with the expertise of a broad base of individual investors, aiming to deliver strong and consistent returns.
The firm's investment strategy focuses on partnering with early-stage companies operating B2B business models and possessing strong intellectual property. Par Equity primarily invests in sectors such as health tech, climate tech, and industrial tech, often driven by new technologies like robotics, photonics, advanced materials, and artificial intelligence. Their portfolio includes companies innovating in fields such as enterprise software, deep tech, and natural capital, reflecting a commitment to supporting groundbreaking technologies and market-leading businesses.
Par Equity's hybrid investment model has garnered industry recognition, including awards like Best EIS Investment Manager in 2021 and 2022, and Angel Group of the Year in 2021 and 2023. The firm is also a certified B Corporation, reflecting its commitment to social and environmental performance. In June 2025, Par Equity announced a merger with Praetura Ventures to create PXN Group, aiming to further accelerate innovation and support the development of the tech ecosystem in the North of the UK.
Requirements
- Early-stage technology companies with high growth potential
- B2B business models
- Strong intellectual property
- Operating in sectors such as health tech, climate tech, industrial tech, robotics, photonics, advanced materials, and artificial intelligence
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Current Health
- Symphonic
- Optoscribe
- DeltaDNA
- Fuuse
Mentioned In
-
$24.95
-
$19.95
-
$19.95
-
$49.95
-
$19.95
-
$19.95
Claim this Investor
Are you an official representative of Par Equity?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim